{
  "docId": "019dd923-622c-750b-8b99-b43d907adb44",
  "docSlug": "3c210b1fcba7",
  "documentTitle": "Tempus AI, Inc. (TEM)",
  "authorId": "54_Spruce_Point_Capital",
  "authorName": "Spruce Point Capital Management",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2025-05-28 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 8,
  "pageCount": 76,
  "prevPage": 7,
  "nextPage": 9,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "balanced",
  "nDataPoints": 6,
  "notes": "The slide uses a narrative-heavy approach to expose potential fraud or financial engineering in corporate partnerships.",
  "elementsJson": [
    "headline_text",
    "paragraph"
  ],
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b99-b43d907adb44/8",
  "deckHref": "/decks/019dd923-622c-750b-8b99-b43d907adb44",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b99-b43d907adb44.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b99-b43d907adb44#slide-8",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "This convoluted structure, involving related parties and non-cash consideration, raises serious questions about the authenticity of reported revenue and backlog.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-fb91-749f-a6ad-6e3c6369f230",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.96,
        "x": 0.02,
        "y": 0.22
      },
      "kind": "paragraph",
      "text": "AstraZeneca: Tempus' partnership with AstraZeneca began in November 2021 with the announcement of a five-year, $200 million Master Services Agreement (\"MSA\")...",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5815dfad-3f8b-42f1-b3cd-c2845df02c84",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.38,
        "w": 0.96,
        "x": 0.02,
        "y": 0.58
      },
      "kind": "paragraph",
      "text": "AstraZeneca / Pathos: Pathos AI (\"Pathos\") is a Lefkofsky-related company being touted as a unicorn with a $1.6 billion valuation...",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "758ea4fe-e7cd-40ee-a251-ab7220001a0e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "\"Insiders Attest That GeneDx Is Actively Committing Widespread Fraud\" — Grizzly Research",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd952-fb91-749f-a6ad-709050588bdd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.96,
        "x": 0.02,
        "y": 0.17
      },
      "kind": "title",
      "text": "Strategic Collaborations: Headline Value, Little Substance, And Related-Party Concerns",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "929f4a02-b642-48ab-84a1-65e9338711e6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.65,
        "x": 0.31,
        "y": 0.05
      },
      "kind": "title",
      "text": "Tempus Has 50% - 60% Downside Risk",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "96d3ac74-dbcf-4a1f-83a9-fe721ccc1ad7",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Action Titles",
      "slug": "action-titles",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "019de87d-eb30-7230-9325-041362289833",
      "evidence": "Title asserts 'Headline Value, Little Substance'",
      "confidence": 88
    },
    {
      "name": "Authority Bias",
      "slug": "authority-bias",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "019de87d-eb5b-71ec-bfee-e03d6a8b71ed",
      "evidence": "Quotes Grizzly Research",
      "confidence": 75
    }
  ],
  "frameworks": [
    {
      "name": "fraud-exposure",
      "slug": null,
      "matchId": "102eb3ac-3178-4b6d-89cc-03d2fe6b5ef1",
      "evidence": "The slide explicitly claims to expose 'related-party concerns' and 'creative deal structuring' to suggest financial misrepresentation.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 11,
      "from": 7,
      "beatId": "019de87d-e3e6-7128-92e2-f4d5dfbf8757",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Solution & Approach",
      "beatSlug": null,
      "evidence": "Strong Sell opinion + 50-60% downside thesis pillars stated upfront.",
      "position": 3,
      "confidence": 78,
      "parentBeatName": null,
      "parentBeatSlug": null
    },
    {
      "to": 11,
      "from": 1,
      "beatId": "019de87d-e4d0-77bf-9508-61d07c6b0663",
      "arcName": "The Mountain",
      "arcSlug": "mountain",
      "beatName": "Setup & Stakes",
      "beatSlug": null,
      "evidence": "Strong Sell thesis with 50-60% downside stake established.",
      "position": 1,
      "confidence": 55,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}